---
title: "To Do: Pass a CHIPS Act for the Biopharma Industry"
summary: |-
  Congress should pass legislation similar to the CHIPS Act to support new biomedical production facilities in the United States.
date: "2020-07-16"
issues: ["National Competitiveness", "Biopharmaceutical Innovation"]
content_type: "Knowledge Base Articles"
canonical_url: "https://itif.org/publications/2020/07/16/to-do-pass-a-chips-act-for-the-biopharma-industry/"
---

# To Do: Pass a CHIPS Act for the Biopharma Industry

# Recommendation

Congress should pass legislation similar to the CHIPS Act for the biopharmaceutical industry.

# Details

Congress should pass the equivalent of the CHIPS Act and American Foundries Act to support the expansion of the U.S. biopharmaceutical industry just as lawmakers did for the semiconductor industry. This would include allocating at least $5 billion per year to states (matched at least with 50 cents in state funding for every $1 in federal funding) to provide incentives for the establishment of new biomedical production facilities in the United States.

**Keep reading:**

- Stephen Ezell, “Ensuring U.S. Biopharmaceutical Competitiveness” (ITIF, July 2020), [https://itif.org/publications/2020/07/16/ensuring-us-biopharmaceutical-competitiveness/](https://itif.org/publications/2020/07/16/ensuring-us-biopharmaceutical-competitiveness/).

---
*Source: Information Technology & Innovation Foundation (ITIF)*
*URL: https://itif.org/publications/2020/07/16/to-do-pass-a-chips-act-for-the-biopharma-industry/*